Mary Durbin, PhD, is Heru’s Chief Science Officer. She has spent 21 years in medical device development, including 7 years at Philips Healthcare and 14 at Carl Zeiss Meditec, Inc. She is an experienced leader of scientific teams developing data analytics and clinical decision support for diagnostic devices from early feasibility work through pivotal clinical testing. Mary is driven by a desire to apply scientific methods and analytical thinking to deliver tools that enable doctors and patients to better understand the data that technology provides to them.